[WS5] Workshop 5 : Prevention, Therapy, and Control | The 73rd Annual Meeting of the Japanese Society for Virology

Session Details

WorkshopWorkshop

[WS5]Workshop 5 : Prevention, Therapy, and Control

Wed. Nov 4, 2026 10:45 AM - 12:00 PM JST
Wed. Nov 4, 2026 1:45 AM - 3:00 AM UTC

Room 2 (2F　Room 201)

Chair: Yuki Furuse (UTOPIA Center, University of Tokyo UTOPIA Center, University of Tokyo)
　　　Masamichi Muramatsu (Department of Infectious Disease Research, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe)

10:45 AM - 11:00 AM JST(1:45 AM - 2:00 AM UTC)

[WS5-1]CCT6A autonomously activates the type I interferon pathway through TRIM21 to inhibit HBV replication

*Yurong Gu¹, Yifan Lian¹, Huaping Xie¹, Hao Hu¹, Jialiang Wang¹, Huan Wei¹ (1. The Third Affiliated Hospital of Sun Yat-sen University)

11:00 AM - 11:15 AM JST(2:00 AM - 2:15 AM UTC)

[WS5-2]Naturally Occurring HIV-1 Capsid Polymorphisms Influence Lenacapavir Resistance Pathways: Implications for Adoption in Sub-Saharan Africa

*Twilumba Makene^1,2,3, Mako Toyoda², Hussein Mti^1,2, Godfrey Barabona^2,3, Manabu Aoki⁴, Doreen Kamori³, Brunno Sunguya³, Takamasa Ueno^2,3 (1. Graduate School of Medical Sciences of Kumamoto University, 2. Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Japan., 3. Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania, 4. Department of Medical Technology, Kumamoto Health Science University, Kumamoto, Japan.)

11:15 AM - 11:30 AM JST(2:15 AM - 2:30 AM UTC)

[WS5-3]Targeting SCD2-dependent lipid metabolism as a broad-spectrum antiviral strategy

*Toshio Kanno¹, Yusuke Endo¹ (1. Kazusa DNA Research Institute)

11:30 AM - 11:45 AM JST(2:30 AM - 2:45 AM UTC)

[WS5-4]Development and Characterization of Neutralizing Nanobodies Against West Nile Virus (WNV) with Therapeutic Potential

*Rasha Eleraky Shalaby^1,2, Teresa Poderoso-García³, Yago Margolles¹, Mercedes Casanova¹, Ana-Belén Blázquez³, Juan Alberto Corbera⁴, Jose´ M. Casasnovas¹, Miguel Ángel Martín-Acebes³, Luis Ángel Fernández¹ (1. Department of Microbial Biotechnology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CNB-CSIC), Madrid, Spain, 2. Department of Basic Medical Sciences, Faculty of Medicine, Galala University, Galala City, Suez, Egypt, 3. Department of Biotechnology, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, Consejo Superior de Investigaciones Científicas (INIA, CSIC), Madrid, Spain, 4. Instituto Universitario de Investigaciones Biomédicas y Sanitarias (IUIBS), Facultad de Veterinaria, Universidad de Las Palmas de Gran Canaria (ULPGC), Campus Universitario de Arucas, Arucas, Spain)

11:45 AM - 12:00 PM JST(2:45 AM - 3:00 AM UTC)

[WS5-5]Generation and Characterization of a Human Monoclonal Antibody That Blocks Hepatitis A Virus Infection in vitro and in vivo

*XIN ZHENG^1,2, Asuka Hirai-Yuki¹, Kazutaka Terahara¹, Noriyuki Watanabe¹, Ryosuke Suzuki¹, Osamu Kotani¹, Bryan Yonish³, Daisuke Yamane⁴, Eriko Ohsaki⁵, Keiji Ueda⁵, Keigo Kawashima¹, Kazuhiro Takimoto¹, Tadaki Suzuki¹, Masanori Isogawa¹, Takayuki Uchihashi⁶, David Stuart⁷, Elizabeth Fry⁷, Stanley M. Lemon³, Yoshimasa Takahashi¹, Masamichi Muramatsu^1,2 (1. Japan Institute for Health Security, NATIONAL INSTITUTE OF INFECTIOUS DISEASES, 2. Foundation for Biomedical Research and Innovation at Kobe, 3. The University of North Carolina at Chapel Hill, 4. Tokyo Metropolitan Institute of Medical Science, 5. Osaka University Graduate School of Medicine, 6. Nagoya University, 7. University of Oxford)

Back to Category List